Summit Therapeutics (MEX:SMMT) Effective Interest Rate on Debt % : 14.70% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Summit Therapeutics Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Summit Therapeutics's annualized positive value of Interest Expense for the quarter that ended in Sep. 2024 was MXN193.36 Mil. Summit Therapeutics's average total debt for the quarter that ended in Sep. 2024 was MXN1,315.70 Mil. Therefore, Summit Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 was 14.70%.

Summit Therapeutics Effective Interest Rate on Debt % Historical Data

The historical data trend for Summit Therapeutics's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Summit Therapeutics Effective Interest Rate on Debt % Chart

Summit Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

40.02

29.50

14.97

1.69

4.69

Summit Therapeutics Quarterly Data
	Oct19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															10.26	10.75	11.45	11.94	14.70

Competitive Comparison of Summit Therapeutics's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Summit Therapeutics's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Summit Therapeutics's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Summit Therapeutics's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Summit Therapeutics's Effective Interest Rate on Debt % falls into.

Summit Therapeutics Effective Interest Rate on Debt % Calculation

Summit Therapeutics's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * -279.413	/	( (10113.803	+	1800.951)	/ 2 )
=	-1 * -279.413	/	5957.377
=	4.69 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	9695.419	+	418.384
=	10113.803

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	1753.27	+	47.681
=	1800.951

Summit Therapeutics's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2024 )	+	Total Debt (Q: Sep. 2024 ))	/ count )
=	-1 * -193.36	/	( (1991.487	+	639.915)	/ 2 )
=	-1 * -193.36	/	1315.701
=	14.70 %

where

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	91.912	+	1899.575
=	1991.487

	Total Debt (Q: Sep. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	82.837	+	557.078
=	639.915

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Summit Therapeutics (MEX:SMMT) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Summit Therapeutics Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Summit Therapeutics's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Summit Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics Inc (MEX:SMMT) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

SMMT:USA

Address

601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131

Website

https://www.smmttx.com

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.